A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome

N-acetylcysteine (NAC), a compound known for its cysteine and glutathione precursor properties, has been used in therapeutic applications for many years. Recently, there has been increasing interest in exploring the potential benefits of NAC in addressing polycystic ovary syndrome (PCOS). However, t...

Full description

Saved in:
Bibliographic Details
Main Author: Pu Yifu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Gynecological Endocrinology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09513590.2024.2381498
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243177946021888
author Pu Yifu
author_facet Pu Yifu
author_sort Pu Yifu
collection DOAJ
description N-acetylcysteine (NAC), a compound known for its cysteine and glutathione precursor properties, has been used in therapeutic applications for many years. Recently, there has been increasing interest in exploring the potential benefits of NAC in addressing polycystic ovary syndrome (PCOS). However, the exact mechanisms underlying NAC’s therapeutic and clinical uses remain not fully understood. This review aims to specifically investigate how NAC offers protection against PCOS. This involved an extensive systematic review of the literature, and it made use of PubMed, Embase, and Web of Science databases. By analyzing key findings from over 100 research papers, the potential mechanisms through which NAC produces its effects were explored and summarized. Most studies suggest that NAC, whether used on its own or in combination with other medications, has the potential to counteract oxidative stress, utilize its anti-inflammatory and anti-apoptotic properties, and offer benefits in managing PCOS. Moreover, NAC might have the potential to influence specific signaling pathways in insulin target cells and β cells. Diverse biological effects of NAC indicate its potential usefulness as a supplementary or therapeutic approach for managing PCOS. As a result, additional research is required to explore its potential in addressing PCOS.
format Article
id doaj-art-40847f0cf6764aeeaeb3b858cb3533e6
institution OA Journals
issn 0951-3590
1473-0766
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Gynecological Endocrinology
spelling doaj-art-40847f0cf6764aeeaeb3b858cb3533e62025-08-20T02:00:03ZengTaylor & Francis GroupGynecological Endocrinology0951-35901473-07662024-12-0140110.1080/09513590.2024.2381498A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndromePu Yifu0Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, ChinaN-acetylcysteine (NAC), a compound known for its cysteine and glutathione precursor properties, has been used in therapeutic applications for many years. Recently, there has been increasing interest in exploring the potential benefits of NAC in addressing polycystic ovary syndrome (PCOS). However, the exact mechanisms underlying NAC’s therapeutic and clinical uses remain not fully understood. This review aims to specifically investigate how NAC offers protection against PCOS. This involved an extensive systematic review of the literature, and it made use of PubMed, Embase, and Web of Science databases. By analyzing key findings from over 100 research papers, the potential mechanisms through which NAC produces its effects were explored and summarized. Most studies suggest that NAC, whether used on its own or in combination with other medications, has the potential to counteract oxidative stress, utilize its anti-inflammatory and anti-apoptotic properties, and offer benefits in managing PCOS. Moreover, NAC might have the potential to influence specific signaling pathways in insulin target cells and β cells. Diverse biological effects of NAC indicate its potential usefulness as a supplementary or therapeutic approach for managing PCOS. As a result, additional research is required to explore its potential in addressing PCOS.https://www.tandfonline.com/doi/10.1080/09513590.2024.2381498N-acetylcysteinepolycystic ovary syndromeoxidative stressclinical medicationcombination therapeutics
spellingShingle Pu Yifu
A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
Gynecological Endocrinology
N-acetylcysteine
polycystic ovary syndrome
oxidative stress
clinical medication
combination therapeutics
title A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
title_full A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
title_fullStr A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
title_full_unstemmed A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
title_short A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
title_sort review of antioxidant n acetylcysteine in addressing polycystic ovary syndrome
topic N-acetylcysteine
polycystic ovary syndrome
oxidative stress
clinical medication
combination therapeutics
url https://www.tandfonline.com/doi/10.1080/09513590.2024.2381498
work_keys_str_mv AT puyifu areviewofantioxidantnacetylcysteineinaddressingpolycysticovarysyndrome
AT puyifu reviewofantioxidantnacetylcysteineinaddressingpolycysticovarysyndrome